These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1178 related articles for article (PubMed ID: 7809506)

  • 1. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Wilms' tumor.
    Coppes MJ; Egeler RM
    Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
    Lahoti C; Thorner P; Malkin D; Yeger H
    Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
    Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetics of Wilms' tumor].
    Papezová M; Mares J; Goetz P
    Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of renal tumors].
    Oláh E; Jakab Z; Balogh E
    Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.